We then determined whether the elevated IL-6 in tumor-bearing mice accounted for the suppression of hepatic Ppara and ketogenesis by administering neutralizing anti-IL-6 antibody to pre-cachectic mice with C26 tumors for 72 hr, during which TFR was imposed for the final 24 hr. Here, IL6 is linked to neoplasm.